openPR Logo

Press Releases from DelveInsight Business Research (6359 total)

Tourette Syndrome Market Trends Point to Steady Growth Ahead by 2034, DelveInsig …

DelveInsight's "Tourette Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Tourette Syndrome, historical and forecasted epidemiology as well as

Global Neurostimulation Devices Market Set to Reach USD 16.11 Billion by 2032, D …

The global neurostimulation devices market is witnessing a transformative growth trajectory, fueled by the increasing burden of chronic neurological disorders, continuous technological advancements, and a

Active Implantable Medical Devices Market to Surpass USD 44.9 Billion by 2032, D …

The global healthcare ecosystem is undergoing a transformative shift toward technology-driven, patient-centric care, and at the forefront of this evolution lies the Active Implantable Medical

Complement 3 Glomerulopathy (C3G) Market to Reach USD 1 Billion by 2036 as Targe …

The Complement 3 Glomerulopathy (C3G) market is poised for significant growth, driven by a deeper understanding of complement pathway dysregulation, improved diagnostic capabilities, and the

Hyperparathyroidism Pipeline Set for Strategic Expansion by 2026 with Advancing …

The Hyperparathyroidism therapeutic landscape is entering a phase of targeted innovation and clinical acceleration, driven by emerging therapies from companies such as Shanghai Hengrui Pharmaceutical

Lupus Nephritis Pipeline Set for Transformational Growth by 2026 with 42+ Therap …

The Lupus Nephritis therapeutic landscape is undergoing a significant transformation, driven by rapid advancements in immunology, cell therapy, and targeted biologics. Companies such as Novartis,

Common Warts Pipeline 2026: Therapies Under Investigation, Clinical Trials Miles …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Common Warts pipeline constitutes 5+ key companies continuously working towards developing 5+ Common Warts

Sarcoidosis Market Expected to Experience Major Growth by 2034, According to Del …

DelveInsight's "Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Sarcoidosis, historical and forecasted epidemiology as well as the Sarcoidosis

Primordial Dwarfism Market: Growth Momentum Across 7MM to 2032 - DelveInsight

DelveInsight's "Primordial Dwarfism Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Primordial Dwarfism, historical and forecasted epidemiology as well as

Chronic Refractory Gout Market: Rapid Increment Driven by Innovation - DelveInsi …

DelveInsight's report, "Chronic Refractory Gout Market Insights, Epidemiology, and Market Forecast-2034," provides a comprehensive analysis of the Chronic Refractory Gout landscape. The report delivers detailed

Atherosclerotic Cardiovascular Disease Market: Expanding Revenue Landscape to 20 …

DelveInsight's "Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology

Myotonic Dystrophy Pipeline Enters a New Era of Genetic Innovation with 20+ Comp …

The Myotonic Dystrophy (DM) therapeutic landscape is witnessing a transformative shift, driven by rapid advancements in RNA-targeted therapies, gene silencing technologies, and precision medicine approaches.

Open-Angle Glaucoma Therapeutic Landscape Set for Transformation as 20+ Pipeline …

The global ophthalmology landscape is undergoing a significant transformation as innovation accelerates in chronic vision disorders, particularly in glaucoma. According to DelveInsight's latest report, "Open

Global Heart Pump Devices Market Set for Exponential Growth, Expected to Reach U …

The global Heart Pump Devices Market is entering a transformative phase marked by rapid technological innovation, increasing disease burden, and a growing reliance on mechanical

Global Neurovascular Devices Market to Surpass USD 8 Billion by 2034, Driven by …

The global Neurovascular Devices Market is entering a transformative growth phase, fueled by the escalating burden of neurological disorders, rapid technological innovation, and increasing adoption

3D Cardiac Mapping System Market to Nearly Double by 2032, Driven by Rising Arrh …

The global 3D Cardiac Mapping System market is entering a transformative growth phase, fueled by the escalating prevalence of cardiovascular disorders, rapid technological advancements, and

Shingles Treatment Pipeline Shows Strong Momentum as 18+ Pharma Companies Advanc …

DelveInsight's "Shingles Pipeline Insight, 2026" report provides comprehensive insights about 18+ companies developing 20+ pipeline drugs in the Shingles pipeline landscape. It covers the Shingles

Congenital Hyperinsulinism Pipeline Gains Momentum with Novel Mechanisms and Adv …

Congenital Hyperinsulinism companies such as Rezolute, Hanmi Pharmaceutical, and other emerging biotech innovators are actively transforming the therapeutic landscape through targeted drug development and precision-based

HPK1 Inhibitors Pipeline Gains Momentum with 10+ Emerging Therapies and Expandin …

The HPK1 inhibitors therapeutic landscape is rapidly evolving as next-generation immuno-oncology strategies continue to gain traction across global markets. Leading pharmaceutical and biotechnology companies, including

BS-01 Sales Forecast to 2034 Signals Breakthrough Opportunity in Blindness Treat …

The global landscape for inherited retinal disease (IRD) therapies is entering a paradigm-shifting era, led by innovative approaches such as optogenetics. Among the most promising

Global Cardiac Arrhythmia Monitoring Devices Market Set to Surge Past USD 9.7 Bi …

The global healthcare landscape is undergoing a profound transformation as cardiovascular diseases continue to rise at an unprecedented rate. Against this backdrop, DelveInsight's latest analysis

Global Positron Emission Tomography Market Set to Surpass USD 3.12 Billion by 20 …

The global Positron Emission Tomography (PET) market is witnessing a transformative phase, characterized by robust growth, technological innovation, and expanding clinical applications. According to DelveInsight's

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma …

The systemic lupus erythematosus (SLE) therapeutic landscape is undergoing a transformative shift, fueled by a surge in clinical research, innovative drug development strategies, and increased

EMB-001 Sales Forecast to 2034 Signals Breakthrough Opportunity in CUD Treatment …

The global addiction therapeutics landscape is on the brink of a paradigm shift as EMB-001, an innovative combination therapy, emerges as a promising solution for

Excessive Daytime Sleepiness Pipeline 2026: FDA Updates, Therapy Innovations, an …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Excessive Daytime Sleepiness pipeline constitutes 10+ key companies continuously working towards developing 12+ Excessive

Complicated Urinary Tract Infection Market 2034: Epidemiology Trends, Innovative …

DelveInsight's "Complicated Urinary Tract Infection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Complicated Urinary Tract Infection, historical and forecasted

Brain Metastasis from Breast Cancer Pipeline 2026: Key Companies, MOA, ROA, and …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Brain Metastasis from Breast Cancer pipeline constitutes 10+ key companies continuously working towards developing

Ascites Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Thera …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies,

Antibody Drug Conjugates Market: Rapid Increment Driven by Innovation by 2034 - …

DelveInsight's "Antibody Drug Conjugates Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as

Spinocerebellar Ataxias Pipeline Advances Toward Breakthrough Therapies with 10+ …

Spinocerebellar Ataxias Companies such as Biohaven Pharmaceuticals, Inc., Steminent US, Inc., Vico Therapeutics B.V., Arrowhead Pharmaceuticals, Neurolixis, and Latus Bio are actively reshaping the future

FDA Grants Full Approval to Kite's Tecartus for Relapsed or Refractory Mantle Ce …

Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted traditional/full approval for Tecartus (brexucabtagene autoleucel) for

Parkinson's Disease Pipeline Enters a New Era with 200+ Therapies and 150+ Compa …

The Parkinson's disease therapeutic landscape is undergoing a transformative shift as over 150 leading biopharmaceutical companies actively advance more than 200 pipeline therapies targeting the

Sjogren's Syndrome Pipeline Gains Strong Momentum with 22+ Therapies Across 20+ …

The Sjogren's syndrome therapeutic landscape is entering a transformative phase, driven by a surge in innovative drug development and increasing research focus on autoimmune modulation.

Multiple System Atrophy Pipeline Gains Momentum with 22+ Therapies in Developmen …

The Multiple System Atrophy (MSA) therapeutic landscape is entering a transformative phase, driven by a surge in innovative drug development and increased scientific focus on

Severe Asthma Pipeline Shows Accelerated Innovation with 50+ Therapies in Develo …

The Severe Asthma therapeutic landscape is witnessing significant transformation, driven by robust research and development efforts from leading biopharmaceutical companies and emerging innovators. Companies such

Amyotrophic Lateral Sclerosis Pipeline Gains Unprecedented Momentum with 100+ Th …

The Amyotrophic Lateral Sclerosis (ALS) therapeutic landscape is undergoing a transformative shift, driven by rapid advancements in neurobiology, gene-targeted therapies, and immunomodulatory approaches. A growing

Irritable Bowel Syndrome Pipeline Poised for Transformational Growth by 2026 wit …

Irritable Bowel Syndrome Companies such as Ardelyx, Tryp Therapeutics, Otsuka Pharmaceutical, RaQualia Pharma, Biomica, Octavian Therapeutics, and others are actively shaping the future of Irritable

Sleep Apnea Devices Market to Surpass USD 15.8 Billion by 2032, Driven by Rising …

The global sleep apnea devices market is undergoing a significant transformation, fueled by rising disease prevalence, technological innovation, and increasing awareness of sleep-related disorders. According

Crovalimab Sales Forecast to 2034 Signals Strong Market Uptake Driven by Monthly …

The global immunology and rare disease treatment landscape is undergoing a significant transformation, with next-generation complement inhibitors redefining standards of care. Among these, Crovalimab has

Next-Generation CAR T-Cell Therapies Reshaping Non-Hodgkin's Lymphoma Treatment …

DelveInsight's report titled "CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive evaluation of CAR T-cell therapy in Non-Hodgkin's

Biliary Tract Cancer Market Set to Grow at a Strong CAGR Through 2036 with 25+ C …

DelveInsight's report titled "Biliary Tract Cancer Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of Biliary Tract Cancer, including both historical and projected

Osteochondrodysplasia Market Outlook to 2034: Clinical Trials, FDA Approvals, Dr …

Osteochondrodysplasia, a group of rare, inherited skeletal disorders characterized by abnormal development of bone and cartilage, presents significant clinical challenges due to its heterogeneity, early

ENT Devices Market to Reach USD 38.58 Billion by 2032, Growing at a 6.30% CAGR D …

The global ENT (Ear, Nose, and Throat) devices market is witnessing a transformative phase, fueled by the convergence of rising disease burden, technological breakthroughs, and

Masitinib Sales Forecast Signals Transformational Growth Potential Across Neurol …

The global pharmaceutical landscape is undergoing a significant transformation, driven by innovation in targeted therapies and precision medicine. Among the emerging therapies gaining notable attention

SLS-005 Sales Market Poised for Strategic Expansion Across Neurodegenerative Dis …

The evolving landscape of neurodegenerative disease therapeutics continues to witness transformative innovation, with SLS-005 (trehalose) emerging as a promising investigational therapy targeting protein aggregation and

Osteoarthritis Pipeline 2026 FDA Updates, Therapy Innovations, and Clinical Tria …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Osteoarthritis pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies,

Fabry Disease Market: Rapid Increment Driven by Innovation by 2034 - DelveInsigh …

DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fabry Disease, historical and forecasted epidemiology as well as

Rett Syndrome Market: Accelerating Growth and Pipeline Impact by 2034 - DelveIns …

DelveInsight's "Rett Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Rett Syndrome, historical and forecasted epidemiology as well as

Glioblastoma Multiforme Market: Rapid Growth & Investment Outlook to 2034 - Delv …

DelveInsight's "Glioblastoma Multiforme Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Glioblastoma Multiforme, historical and forecasted epidemiology as well as

Follicular Lymphoma Market: Strong Pharma Growth Forecast Through 2034 - DelveIn …

FelveInsight's "Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Follicular Lymphoma, historical and forecasted epidemiology as well as

Go To Page:    1 2 3 4 5 6 7 8 9 10 41 42 43 44 45 46 47 48 49 50